National Mission Achieves 7.25 Crore Sickle Cell Screenings

India has achieved a major milestone in public health outreach. Specifically, over 7.25 crore sickle cell anaemia screening tests have been conducted in tribal regions as of July 26. Union Health Minister J P Nadda presented these updated findings in the Lok Sabha. Furthermore, health facilities are screening individuals aged zero to forty years to ensure early diagnosis and intervention.

Expanding Sickle Cell Anaemia Screening and Healthcare Facilities

Screening operations cover seventeen states with significant tribal populations, including Maharashtra. Consequently, public health centers from district hospitals down to Ayushman Arogya Mandirs participate actively. In addition, Maharashtra alone accounts for over 1.11 crore completed tests. Public health remains a state subject in India. Therefore, the Union Health Ministry provides crucial technical and financial support through National Health Mission plans.

Drug Infrastructure and Specialized Treatment Support

Besides early detection, essential medical management remains a high priority for clinicians. For example, the government included Hydroxyurea in the essential drugs list for primary and secondary health centers. Additionally, authority teams track drug supply through the Drugs and Vaccine Distribution Management System portal. Thus, health centers maintain steady inventories of critical life-saving medications.

Moreover, seventeen Centers of Excellence have received approval across fifteen states, including AIIMS Nagpur. The Ministry of Tribal Affairs funds these advanced referral centers. Meanwhile, medical experts offer crucial counselling on lifestyle, pre-marital genetic risks, and pre-natal decisions. Research hubs like ICMR-NIRTH Jabalpur also deliver vital diagnostic support for national management programs.

Frequently Asked Questions

Q1: What is the primary target group for sickle cell screening in India?

The screening initiative targets individuals between the ages of 0 and 40 years across tribal-dominated regions in 17 high-focus states.

Q2: How is drug availability ensured for sickle cell patients in rural areas?

Hydroxyurea is included on the essential drugs list across primary and secondary health facilities, while inventory is monitored using the online DVDMS portal.

Q3: What role do Centers of Excellence play in managing sickle cell disease?

Seventeen approved Centers of Excellence provide tertiary care, specialized management, genetic counselling, and research support for complex sickle cell cases.

References

1. 7.25 cr screenings for sickle cell anaemia conducted in tribal areas till July26: Nadda – ETHealthworld
2. National Sickle Cell Anaemia Elimination Mission Guidelines – Ministry of Health and Family Welfare, Government of India
3. Operational Guidelines for Prevention and Control of Hemoglobinopathies in India – National Health Mission

Disclaimer: This article was automatically generated from publicly available sources and is provided for informational and educational purposes only. OC Academy does not exercise editorial control or claim authorship over this content. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider and refer to current local and national clinical guidelines.